Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S2213-2600(23)00216-3 | DOI Listing |
Publication Analysis
Top Keywords
befotertinib-a viable
4
viable alternative
4
alternative egfr-mutant
4
egfr-mutant advanced
4
advanced nsclc?
4
befotertinib-a
1
alternative
1
egfr-mutant
1
advanced
1
nsclc?
1
Similar Publications
Befotertinib-a viable alternative in EGFR-mutant advanced NSCLC?
Lancet Respir Med
October 2023
Paris-Saclay University, Institut Gustave Roussy, Villejuif, France.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!